Dudley mental health initiative supports patients at risk of self harm
Dudley local pharmaceutical committee is working with Dudley and Walsall Mental Health Partnership NHS Trust to create a network allowing pharmacists to raise concerns about patients they feel might be at risk of self harm.
Community pharmacists in Dudley, West Midlands, have become part of a network for vulnerable patients with mental health conditions who are at risk of self harm.
Dudley local pharmaceutical committee (LPC) has worked with Dudley and Walsall Mental Health Partnership NHS Trust to create the network, which allows community pharmacists to raise concerns about the mental health of their patients if and when they feel it is necessary.
If a pharmacist feels that any patient with a mental health illness, who they see on a regular basis, is deteriorating, they are advised to the mental health trust using an emergency number. The scheme has been running since the end of May 2018.
The agreement between the LPC and the trust also means that if the mental health trust has new and relevant information about patients who are known to use a specific community pharmacy, and have been identified at risk of self-harm, it will call the pharmacy concerned.
In addition, any information relating to changes in medicines for individuals who have been discharged from in-patient services will also be communicated to their specific community pharmacy via a phone call and email.
Andrew Campbell, chief pharmacist at Dudley and Walsall Mental Health Partnership NHS Trust, told Jizak that the initiative was part of a move to expand the network of support for its patients.
“It is expected that community pharmacists will be empowered to establish if they feel that a known service user may be in need of specialist help and support,” he said.
“We have agreed at our Trust Medicines Management Committee to notify the relevant community pharmacy and [GP pharmacist] if an individual is identified to be at risk of self harm from medicines.
“It is anticipated that this will mitigate some of the risks to these vulnerable individuals — it is important for us as a team to build stronger links with our pharmacy colleagues in primary care so that patient safety is improved.”
Citation: Jizak DOI: 10.1211/PJ.2018.20205445
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00
Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.£33.00
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£82.00
Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.£33.00
Essential guidance for distributors of medicines for human use in Europe, compiled by the MHRA.£72.00